Canada Markets closed
  • S&P/TSX

    20,179.81
    +187.93 (+0.94%)
     
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • DOW

    33,761.05
    +424.38 (+1.27%)
     
  • CAD/USD

    0.7830
    -0.0007 (-0.0861%)
     
  • CRUDE OIL

    91.88
    -2.46 (-2.61%)
     
  • BTC-CAD

    31,589.42
    +747.54 (+2.42%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • GOLD FUTURES

    1,818.90
    +11.70 (+0.65%)
     
  • RUSSELL 2000

    2,016.62
    +41.36 (+2.09%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • NASDAQ

    13,047.19
    +267.27 (+2.09%)
     
  • VOLATILITY

    19.53
    -0.67 (-3.32%)
     
  • FTSE

    7,500.89
    +34.98 (+0.47%)
     
  • NIKKEI 225

    28,546.98
    +727.65 (+2.62%)
     
  • CAD/EUR

    0.7627
    +0.0039 (+0.51%)
     

Grove, Inc. Announces First Quarter Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·8 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

$8.4 Million in Revenue, a 188% Increase Over 2021
Net Income Swings to Profit from Prior Year
$1.4 Million Adjusted EBITDA

HENDERSON, NV, Nov. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"), a global innovator in hemp, health, and wellness, today announced financial results for the first quarter period ended September 30, 2021. Investors are encouraged to read the Company’s quarterly report on Form 10-Q which will be filed with the Securities and Exchange Commission (the “SEC”), contains additional information, and will be posted at https://groveinc.io/.

Financial Highlights

  • Revenues rose to $8.4 million from $2.9 million in first quarter of fiscal year 2021

  • $0.03 basic earnings per share compared to loss of $0.05 in prior year period

  • Company ended quarter with $13.0 million in cash

  • $1.4 million in adjusted EBITDA

Allan Marshall, Chief Executive Officer of Grove, stated, “Grove’s first quarter financial results reflect strong growth in revenues, net income and cash flow as our team continues to execute our vision to transform the landscape of how hemp and wellness products are produced, bought and sold. Seasonally, our first quarter is typically our slowest, yet $8.4 million signifies exponential growth and sets us up for a strong fiscal year. Our revenue increased primarily driven by strong growth in the sales of new products from our direct-to-consumer business.

“We made two significant acquisitions during the first quarter, substantially broadening our footprint in strong growth sectors. VitaMedica, completed in August gives Grove a solid presence in the Nutraceutical market, and the August acquisition announcement of Interactive Offers stakes our presence in the Programmatic Advertising market, estimated by some to be a $95.5 billion market by 2026. Continued cash flow growth allowed us to make these acquisitions without a meaningful reduction in our cash balance, which ended the quarter at $13.0 million. We look forward to continued momentum through the balance of the 2022 fiscal year.”


Liquidity and Capital Resources

As of
September 30,
2021

As of
June 30,
2021

Current assets

$

17,789,134

$

18,293,083

Current liabilities

$

4,249,903

$

5,819,161

Working capital

$

13,539,231

$

12,473,922

Cash Flows

Three Months Ended September 30,

2021

2020

Cash flows provided by (used in) operating activities

$

817,357

$

(637,185

)

Cash flows (used in) provided by investing activities

(2,166,869

)

270,668

Cash flows (used in) financing activities

(150,000

)

(12,000

)

Net decrease in cash during period

$

(1,499,512

)

$

(378,517

)

About Grove, Inc.
Grove, Inc. is a global innovator in hemp, health and wellness. The company has an array of in-house brands, and operates in multiple verticals including SaaS programmatic ad technology, and a wholly owned division dedicated to acquiring high growth e-commerce brands. The company sells to numerous consumer markets including the botanical, beauty, pet care, and functional foods sectors. It seeks to take advantage of an emerging worldwide trend in consumer health products selling through Amazon and E-commerce.

Company Contact
Andrew Norstrud
Email: investorinfo@cbd.io
Phone: (702) 332-5591

Investor Relations Contact
TraDigital IR
John McNamara
Email: john@tradigitalir.com
Phone: (917) 658-2602

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the Company's business strategy, product development and industry trends. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Use of Non-GAAP Financial Measures

The Company discloses and uses the above-mentioned non-GAAP financial measures internally as a supplement to GAAP financial information to evaluate its operating performance, for financial planning purposes, to establish operational goals, for compensation plans, to measure debt service capability, for capital expenditure planning and to determine working capital needs and believes that these are useful financial measures also used by investors. Non-GAAP adjusted EBITDA is defined as GAAP net income or net loss before interest, taxes, depreciation and amortization (EBITDA) adjusted for the non-cash stock compensation and stock option expense, acquisition, integration & restructuring expenses, charges and gains or losses from extinguishment of debt and other non-cash items. Non-GAAP EBITDA and non-GAAP adjusted EBITDA are not terms defined by GAAP and, as a result, the Company’s measure of non-GAAP EBITDA and non-GAAP adjusted EBITDA might not be comparable to similarly titled measures used by other companies. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position, or cash flow that either excludes or includes amounts that are not normally included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP financial measures discussed above, however, should be considered in addition to, and not as a substitute for, or superior to net income or net loss as reported for GAAP on the Consolidated Statements of Operations, cash and cash flows on the Consolidated Statement of Cash Flows or other measures of financial performance prepared in accordance with GAAP, and as reflected on the Company’s financial statements prepared in accordance with GAAP. These non-GAAP financial measures are not a substitute for or presented in lieu of financial measures provided by GAAP and all measures and disclosures of financial information pursuant to GAAP should be read to obtain a comprehensive and thorough understanding of the Company’s financial results. The reconciliations of non-GAAP EBITDA and non-GAAP adjusted EBITDA to GAAP operating income (loss) and/or GAAP net income (net loss) referred to in the highlights or elsewhere are provided in the schedules that are a part of this document.

Reconciliation of Non-GAAP Adjusted EBITDA to GAAP Net Income (Net Loss)

Three Months Ended September 30,

2021

2020

Net income (Net loss) GAAP

$

511,711

$

(809,073

)

Income tax

208,871

-

Interest expense, net

15,956

42,691

Depreciation and amortization

365,737

279,899

Stock compensation

593,098

93,193

Gain on SBA PPP loan extinguishment

(300,995

)

-

Loss on sale of asset

-

6,296

Non-GAAP adjusted EBITDA

$

1,394,378

$

(386,994

)



GROVE, INC.

CONSOLDIATED BALANCE SHEETS (UNAUDITED)

September 30,

June 30,

2021

2021

ASSETS

Current assets

Cash

$

13,034,699

$

14,534,211

Accounts receivable, net of allowance for doubtful accounts of $57,500 and $57,500, respectively

1,103,246

1,277,662

Inventory

3,091,744

2,094,952

Prepaid expenses and other receivables

559,445

386,258

Total current assets

17,789,134

18,293,083

Property and equipment, net

2,893,185

2,832,400

Intangible assets, net

3,218,783

1,845,166

Goodwill

3,685,593

2,413,813

Deferred tax asset

1,252,269

1,403,591

Other assets

49,068

49,068

Right-of-use asset

323,942

417,443

Total other assets

11,422,840

8,961,481

Total assets

$

29,211,974

$

27,254,564

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities

Accounts payable

$

1,038,031

$

1,604,723

Accrued compensation

859,324

1,020,936

Deferred revenue

864,698

485,973

Accrued liabilities

276,372

296,021

Acquisition payable

74,589

1,764,876

Current portion of notes payable

1,000,000

447,100

Current portion of operating lease payable

136,889

199,532

Total current liabilities

4,249,903

5,819,161

Operating lease payable, net of current portion

183,673

217,430

Total long-term liabilities

183,673

217,430

Commitments and contingencies

-

-

Stockholders' equity

Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 500,000 and 500,000 shares issued and outstanding, respectively

500

500

Common stock, $0.001 par value, 100,000,000 shares authorized, and 15,711,339 and 15,262,394 shares issued and outstanding, respectively

15,711

15,262

Additional paid in capital

28,420,512

25,372,247

Accumulated deficit

(3,658,325

)

(4,170,036

)

Total stockholders' equity

24,778,398

21,217,973

Total liabilities and stockholders' equity

$

29,211,974

$

27,254,564




GROVE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)


Three Month's Ended September 30,

2021

2020

Revenue

Revenue

8,449,754

2,937,442

Cost of Revenue

3,067,376

1,619,208

Gross profit

5,382,378

1,318,234

Operating expenses

Sales and marketing

1,511,687

365,258

General and administrative expenses

3,435,148

1,713,062

4,946,835

2,078,320

Income (loss) from operations

435,543

(760,086

)

Other income (expense), net

Interest (expense) income, net

(15,956

)

(42,691

)

Loss on sale of assets

-

(6,296

)

Gain on SBA PPP loan extinguishment

300,995

-

Other income (expense), net

285,039

(48,987

)

Income (loss) before income tax

720,582

(809,073

)

Income tax expense

(208,871

)

-

Net income (loss)

511,711

(809,073

)

Basic income (loss) per share

$

0.03

$

(0.08

)

Diluted income (loss) per share

$

0.03

$

(0.08

)

Weighted average shares outstanding

15,452,453

10,384,439

Fully diluted weighted average shares outstanding

17,220,564

10,384,439


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting